Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Tagged with Invokana

Invokana linked to flesh-eating genital infections. According to the latest FDA warnings Invokana, Jardiance, Farxiga and similar diabetes drugs increase the risk of serious genital infections.

The FDA issued a warning earlier this week, warning that the drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors increase the risk of serious genital infections.

The genital infections involve necrotizing fasciitis of the perineum, also known as Fournier’s gangrene, and “flesh-eating” infection.

Invokana Injury side effects lawsuits on the rise. As the number of patients afflicted with diabetes continues to rise in the United States, so do the risks of serious Invokana Injury side effects from the popular diabetic medication.

Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs.

Invokana Injury side effects claims now over 1,000

Invokana Wrongful Death Lawsuit. Loretta Jack recently filed an Invokana wrongful death lawsuit against the makers of the blockbuster type 2 diabetic medication Invokana in the U.S. District Court for the District of New Jersey. According to Jack, her husband, Raymond Jack, Sr., died from catastrophic complications from the Invokana drug.

Jack filed the Invokana wrongful death lawsuit against Johnson & Johnson and it’s Janssen Pharmaceutical’s subsidiary, claiming that the Invokana drug caused severe kidney failure, diabetic ketoacidosis, and stroke.

According to Jack, her husband took Invokana for treatment of his diabetes in March 2015, and he was hospitalized within a couple of months, developing an acute stroke and kidney failure. He later died from the overwhelming complications from the acute injuries.

Invokana Amputation Settlement Lawsuit. In order to qualify for an Invokana or Invokamet amputation lawsuit settlement, a patient must have taken Invokana or Invokamet and developed serious amputation side effects involving toes, feet or leg amputations.

Johnson & Johnson the world’s largest pharmaceutical and medical device maker and its Janssen subsidiary are under the hammer over serious allegations that the companies failed to warn about severe side effects from its blockbuster line of new diabetic medications.

The allegations at the heart of many similar product liability and personal injury lawsuits are that the companies failed to provide adequate warnings about the potential side effects of Invokana and Invokamet.

Invokana Diabetes Amputee Lawsuits. Michael Nickels recently filed a product liability and personal injury claim in the U.S. District Court for the District of New Jersey over claims of amputation as a result of taking the diabetic medication.

According to Nickels, Johnson & Johnson, the world’s largest pharmaceutical company, and its Janssen Pharmaceuticals subsidiary knew or should have known about the potential amputee side effects of Invokana, but withheld and hid information from patients and doctors about the severity of the amputee risks.

Mickels used Invonaka for the treatment of his type 2 diabetes in 2014, but within two years Mickels had to get an amputation procedure, from the use of the drug.

Texas Invokana Diabetic Ketoacidosis Lawsuit. Ronney Lyons, from Houston, Texas recently filed an Invokana product liability and personal injury lawsuit against Janssen Pharmaceuticals and its parent company, Johnson & Johnson.

According to Lyons in his Texas Invokana Diabetic Ketoacidosis lawsuit, the serious side effects of Invokana type 2 diabetes medication caused him to develop diabetic ketoacidosis injury.

Invokana Diabetic Ketoacidosis Injury

Invokana Injury Lawsuit. Martha Williams, from Tennessee, recently filed an Invokana product liability and personal injury lawsuit against Janssen Pharmaceuticals and it’s parent company, Johnson & Johnson. According to Williams, in her Invokana injury lawsuit, the serious side effects of Invokana caused her to develop acute renal failure, and urinary tract infection.

What is Invokana?

Invokana (canagliflozin) is a new type 2 diabetic medication released in March 2013, and has been touted by Janssen Pharmaceuticals and Johnson & Johnson as being superior to the older types of diabetic medications.

Invokana Wrongful Death Lawsuit. Scott Martin from Alabama alleges that the side effects of the blockbuster diabetic drug Invokana caused the wrongful death of his wife. According to Martin, his wife suffered severe diabetic ketoacidosis and congestive heart failure, leading to her death.

Martin filed his claim, on behalf of himself and his late wife, Sheila Martin, in the U.S. District Court for the District of New Jersey, naming Johnson & Johnson and its Janssen Pharmaceuticals subsidiary as defendants.

Martin claims that Janssen and Johnson & Johnson actively hid the Invokana risks from patients and doctors, providing false and misleading information on the warning label.

The number of lawsuits filed by people who say they suffered serious side effects after taking Invokana (canagliflozin) continues to grow in Philadelphia amid rising safety concerns. Attorneys are also investigating other drugs in the Type 2 diabetes drug class known SGLT2 inhibitors.

While attorneys across the country are filing lawsuits on behalf of local plaintiffs, Pennsylvania is seeing a large number of cases. Dozens of cases made their way to Philadelphia. An attorney family with the cases told a reporter at the Legal Intelligencer that more than 150 suits are pending in Missouri and Illinois.

Attorneys say a judge may consolidate the cases if the volume continues to grow.

Two years after the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson’s Invokana, the FDA issued a drug safety communication that warned doctors and patients that Invokana may lead to diabetic ketoacidosis (DKA). According to recent lawsuits, the makers of Invokana knew or should have known about diabetic ketoacidosis but failed to warn consumers.

Invokana is a new class of Type 2 diabetes drug called sodium-glucose co-transporter 2 (SGLT2). This class of Type 2 diabetes drugs work by stopping glucose from being reabsorbed into the blood. The FDA approved Invokana in 2013. In May 2015 the FDA release a statement warning patients and doctors that SGLT2 drugs may lead to DKA. If DKA is left untreated, it can be fatal.

In December 2015, the FDA ordered manufacturers of SGLT2 inhibitors to add warnings regarding the risk of urinary tract infection and ketoacidosis to the drugs’ labels.

Contact Information